BioRem (CVE:BRM) Hits New 12-Month High – Should You Buy?

BioRem Inc. (CVE:BRM) shares hit a new 52-week high during mid-day trading on Monday . The stock traded as high as C$3.45 and last traded at C$3.35, with a volume of 141939 shares changing hands. The stock had previously closed at C$3.22.

Wall Street Analyst Weigh In

Separately, Cormark upgraded shares of BioRem to a “moderate buy” rating in a research report on Tuesday, December 17th.

BioRem Stock Up 4.0 %

The firm has a market cap of C$52.60 million, a price-to-earnings ratio of 15.95 and a beta of 0.85. The company has a quick ratio of 1.08, a current ratio of 1.57 and a debt-to-equity ratio of 48.97. The firm has a fifty day moving average price of C$2.97 and a 200-day moving average price of C$2.51.

Insiders Place Their Bets

In other news, Director Derek Webb sold 120,000 shares of the company’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of C$2.93, for a total transaction of C$351,600.00. 1.90% of the stock is owned by corporate insiders.

About BioRem

BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.